US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

AQR Capital Holdings

1,736.22

-62.0656-3.45%

Number of Gainers:31

Number of Losers:66

Number of Flat:- -

PE:- -

High:1,796.51

Open:1,796.51

Low:1,731.39

Close:1,798.29

Loading ...

Pharma Stock Roundup: BAYRY's Q4 Results, ABBV's Obesity Deal & More

Elon Musk Misses Fat Target For Cost Cuts: His Own Company

Verizon to speak at Deutsche Bank Conference March 11

InflaRx Showcases Vilobelimab’s Role in Immuno-Dermatology at the 2025 AAD Annual Meeting

These are Elon Musk’s top lieutenants—including at DOGE

Pakistan nearing $4.4 billion loan to ease power sector debt

Vertex Pharmaceuticals' Triple Combination Cystic Fibrosis Therapy Alyftrek Receives Approval in UK

MT Newswires Live

Goldman Sachs Remains a Buy on Venture Global, Inc. Class A (VG)

Broadcom (AVGO): New Buy Recommendation for This Technology Giant

Humana Says CEO James a. Rechtin's 2024 Total Compensation Was $15.6 Mln – SEC Filing

THOMSON REUTERS

Stifel Nicolaus Remains a Buy on Costco (COST)

Broadcom's AI Boom Lifts Q1 Results, Stock Jumps Over 11% in Pre-Market

Goldman Traders Say Stock Rally Hinges on Knife-Edge Jobs Data

Johnson & Johnson Unit's Lazertinib With Amivantamab Approved in UK for Non-Small Cell Lung Cancer

MT Newswires Live

Market Chatter: Goldman Sachs Pushes Some Senior Staff to Relocate or Quit

MT Newswires Live

Positive Outlook for Jazz Pharmaceuticals: Buy Rating Backed by Strong Growth Prospects and Strategic Focus

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4533/news?page=16"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4533"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4533\",,,,,undefined,":{"symbol":"BK4533","market":"US","secType":"PLATE","nameCN":"AQR Capital Holdings","latestPrice":1736.221,"timestamp":1741631527110,"preClose":1798.2865,"halted":0,"volume":1034617791,"delay":0,"changeRate":-0.034514,"change":-62.065552,"pbRate":6.882193,"amount":155606366711.7098,"amplitude":0.036215,"prevYearClose":1876.573,"fiveDayClose":1803.3612,"twentyDayClose":1882.5758,"turnoverRate":0.005787,"marketCap":31959279952896,"floatMarketCap":29869219401728,"peRate":27.966651},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4533\",,,,,undefined,":{"symbol":"BK4533","high":1796.5128,"amplitude":0.036215,"preClose":1798.2865,"low":1731.3884,"pbRate":"6.882193","latestPrice":1736.221,"volume":1034617791,"delay":0,"open":1796.5128,"prevYearClose":1876.573,"prevWeekClose":1798.2865,"prevMonthClose":1844.0504,"prevQuarterClose":1876.573,"fiveDayClose":1803.3612,"twentyDayClose":1882.5758,"sixtyDayClose":1892.4408,"secType":"PLATE","market":"US","turnoverRate":0.005787,"peRate":27.966651,"marketCap":31959279952896,"floatMarketCap":29869219401728,"timestamp":1741631527110,"nameCN":"AQR Capital Holdings"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4533\",,,,undefined,":{"bkCode":"BK4533","up":31,"down":66,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4533\",pageSize:16,pageCount:16,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517643107","title":"Pharma Stock Roundup: BAYRY's Q4 Results, ABBV's Obesity Deal & More","url":"https://stock-news.laohu8.com/highlight/detail?id=2517643107","media":"Zacks","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517643107?lang=en_us&edition=fundamental","pubTime":"2025-03-07 21:09","pubTimestamp":1741352940,"startTime":"0","endTime":"0","summary":"This week, Bayer BAYRY announced its fourth-quarter and full-year 2024 results. AbbVie ABBV announced a licensing deal with Danish firm Gubra for an amylin-targeting obesity treatment, which marked the company’s entry into the obesity space. Novo Nordisk NVO announced that it is cutting the price of its popular obesity injection, Wegovy, for the uninsured following a similar move byrival Eli Lilly. J&J JNJ discontinued a phase III study on a candidate being evaluated as an adjunctive treatment for major depressive disorder . The FDA accepted Roche’s RHHBY application seeking expanded use of its lymphoma drug, Gazyva/Gazyvaro, for the treatment of lupus nephritis.Here's a recap of the week’s most important stories.Novo Nordisk is launching a new direct-to-patient online pharmacy called NovoCare, which will offer Wegovy at a discounted price of $499 per month, less than half of its listed price. This offer is for patients who do not have insurance coverage and pay by cash as well as thos","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pharma-stock-roundup-bayrys-q4-130900621.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Pharma Stock Roundup: BAYRY's Q4 Results, ABBV's Obesity Deal & More","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1261432733.SGD","LU0098860793.USD","NVO","RHHBY","BK4007","BK4533","LU0795875169.SGD","SG9999011175.SGD","LU1003077747.HKD","LU1718418525.SGD","LU0965508806.USD","LU1267930490.SGD","IE0002141913.USD","LU2237443465.HKD","LLY","LU2347655156.SGD","LU0912757837.SGD","LU1221951129.SGD","LU0211327993.USD","LU0553294199.USD","IE0004445239.USD","IE00B3PB1722.GBP","IE00BJJMRZ35.SGD","LU2505996509.AUD","SG9999015945.SGD","BK4566","BK4581","BAYRY","LU1551013425.SGD","IE00B42XCP33.USD","LU1989771016.USD","LU1066053197.SGD","ABBV","03165","IE00BDGV0183.EUR","IE00BJT1NW94.SGD","LU0234572021.USD","IE00B1BXHZ80.USD","LU0689472784.USD","LU1914381329.SGD","IE00B2B36J28.USD","LU1732800096.USD","LU0949170772.SGD","LU0965509010.AUD","LU1093756325.SGD","BK4585","LU2087621335.USD","LU1196500208.SGD","JNJ","LU0545039389.USD","BK4592"],"gpt_icon":1},{"id":"2517961434","title":"Elon Musk Misses Fat Target For Cost Cuts: His Own Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2517961434","media":"Blockhead","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517961434?lang=en_us&edition=fundamental","pubTime":"2025-03-07 21:00","pubTimestamp":1741352414,"startTime":"0","endTime":"0","summary":"Elon Musk's DOGE is seeking to cut inefficiency in the U.S. government. But maybe he could start with a target closer to him: his own Tesla.","market":"hk","thumbnail":"https://www.investors.com/wp-content/uploads/2025/03/Sector030625AP-150x150.jpg","type":0,"news_type":0,"thumbnails":["https://www.investors.com/wp-content/uploads/2025/03/Sector030625AP-150x150.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.investors.com/etfs-and-funds/sectors/elon-musk-misses-bloated-target-for-cost-cuts-his-own-company-sp500/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investor_business_daily_highlight","symbols":["LU2023250330.USD","ESmain","LU1914381329.SGD","SH","LU0648001328.SGD","BK4596","BK4099","LU2756315318.SGD","SPXU","LU2357305700.SGD","SSO","LU0162691827.USD","IVV","TSYW.SI","UPRO","VOO","LU0006061336.USD","LU1366192091.USD","TSLL","LU0077335932.USD","OEF","OEX","LU0820561909.HKD","GM",".SPX","LU1066051811.HKD","LU0823411888.USD","LU0820561818.USD","SDS","LU2602419157.SGD","LU1201861165.SGD","TSLA","LU0320765489.SGD","LU0130517989.USD","LU1861215975.USD","F","LU2750360641.GBP","SPY","LU1852331112.SGD","LU2471134796.USD","VICI","BK4561","SG9999015978.USD","BK4533","BK4084","IE00BSNM7G36.USD","BK4612","LU1861558580.USD","LU0072461881.USD"],"gpt_icon":1},{"id":"2517480571","title":"Verizon to speak at Deutsche Bank Conference March 11","url":"https://stock-news.laohu8.com/highlight/detail?id=2517480571","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517480571?lang=en_us&edition=fundamental","pubTime":"2025-03-07 21:00","pubTimestamp":1741352400,"startTime":"0","endTime":"0","summary":"NEW YORK, March  07, 2025  (GLOBE NEWSWIRE) -- Frank Boulben, senior vice president and chief revenue officer for the Consumer Group of Verizon (NYSE, Nasdaq: VZ), is scheduled to speak at the Deutsch","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/07/3038901/0/en/Verizon-to-speak-at-Deutsche-Bank-Conference-March-11.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BSNM7G36.USD","BK4115","LU0225771236.USD","BK4118","BK4585","LU1621767810.EUR","LU0321505868.SGD","LU0306806265.USD","LU1430594728.SGD","LU1162221912.USD","BK4515","LU1621767737.EUR","LU1621768206.USD","LU1914381329.SGD","LU2384288077.EUR","LU0985481810.HKD","BK4566","LU1366192091.USD","BK4552","LU0942090050.USD","DB","LU0098860793.USD","LU1066053197.SGD","LU1059921491.USD","LU1621768115.EUR","LU0225284248.USD","LU1585245621.USD","LU1066051498.USD","LU0868494617.USD","BK4581","BK4534","BK4588","BK4559","LU1571399168.USD","BK4550","LU0306807586.USD","LU0320765646.SGD","LU1066051225.USD","VZ","LU1699723380.USD","LU0321505439.SGD","LU1066051811.HKD","BK4533","LU0868494708.USD"],"gpt_icon":0},{"id":"2517480505","title":"InflaRx Showcases Vilobelimab’s Role in Immuno-Dermatology at the 2025 AAD Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2517480505","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517480505?lang=en_us&edition=fundamental","pubTime":"2025-03-07 21:00","pubTimestamp":1741352400,"startTime":"0","endTime":"0","summary":"JENA, Germany, March  07, 2025  (GLOBE NEWSWIRE) -- InflaRxN.V.(Nasdaq:IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/07/3038913/0/en/InflaRx-Showcases-Vilobelimab-s-Role-in-Immuno-Dermatology-at-the-2025-AAD-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4567","LU1066051498.USD","BK4018","LU2129689431.USD","LU2129689514.USD","BK4139","BK4558","LU2552382215.SGD","PD","PG","ARDS","IE00BLSP4239.USD","SG9999002232.USD","LU1868836914.USD","LU0234572021.USD","USA","BK4568","LU1066053197.SGD","SG9999014542.SGD","SG9999001440.SGD","LU0094547139.USD","LU1169589451.USD","SG9999014575.USD","BK4504","BK4535","BK4181","LU0061475181.USD","LU1929549753.HKD","BNTX","BK4534","BK4559","IE00B3T34201.USD","IE00BWXC8680.SGD","LU1868837136.USD","IE00BBT3K403.USD","LU0868494617.USD","LU1162221912.USD","LU1430594728.SGD","SG9999015341.SGD","LU1868837300.USD","SG9999015358.SGD","LU1585245621.USD","PK","SG9999002224.SGD","LU1868836591.USD","BK4581","SG9999014567.USD","LU0234570918.USD","BK4533","LU0689626769.HKD"],"gpt_icon":0},{"id":"2517434881","title":"These are Elon Musk’s top lieutenants—including at DOGE","url":"https://stock-news.laohu8.com/highlight/detail?id=2517434881","media":"Fortune","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517434881?lang=en_us&edition=fundamental","pubTime":"2025-03-07 20:53","pubTimestamp":1741352036,"startTime":"0","endTime":"0","summary":"This is Luisa Beltran, finance reporter, subbing for Allie.One theme became clear in building our charts. Musk, who has six companies, including Tesla, relies on several highly valued executives to help manage them. One of Musk’s top lieutenants is Steve Davis, an aerospace engineer who spent several years working at Musk’s space cargo business SpaceX before joining Musk’s tunneling startup The Boring Company in 2016. People who have worked with Davis think he can get any job done, no matter how seemingly unrealistic. After Musk closed his $44 billion Twitter acquisition in 2022, Davis, who is president of Boring, helped reorganize the social media company that is now known as X.  See Fortune’s Boring chart here.Davis, along with Hollander, are now helping with Musk’s latest initiative: DOGE. The mandate is to reduce the size of government and cut federal spending by $2 trillion. Like many things Musk, DOGE has gotten off to a quick start, playing a large role in laying off thousands o","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/elon-musk-top-lieutenants-including-125356437.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0689472784.USD","BK4574","LU0323591593.USD","LU1674673428.USD","LU2360107168.USD","BK4099","LU0719512351.SGD","LU0345769128.USD","LU2290526834.HKD","TSYW.SI","BK4534","LU2360106780.USD","BK4592","BK4588","LU1066051225.USD","LU1551013425.SGD","LU2063271972.USD","SG9999015945.SGD","LU1066053197.SGD","LU0077335932.USD","TSLL","LU2471134523.USD","LU2249611893.SGD","IE00B1XK9C88.USD","LU1066051811.HKD","LU0823411888.USD","LU0943347566.SGD","LU0820561818.USD","LU0234570918.USD","LU1066051498.USD","LU2087621335.USD","LU0345769631.USD","BK4581","TSLA","LU1551013342.USD","LU1548497426.USD","LU1435385759.SGD","LU0056508442.USD","LU2108987350.USD","LU1778281490.HKD","LU2471134952.CNY","LU0345770308.USD","LU0316494557.USD","LU0964807845.USD","BK4533","LU1839511570.USD","IE00BSNM7G36.USD","BK4612","LU0820562030.AUD"],"gpt_icon":1},{"id":"2517482405","title":"Pakistan nearing $4.4 billion loan to ease power sector debt","url":"https://stock-news.laohu8.com/highlight/detail?id=2517482405","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517482405?lang=en_us&edition=fundamental","pubTime":"2025-03-07 20:47","pubTimestamp":1741351628,"startTime":"0","endTime":"0","summary":"Pakistan nearing $4.4 billion loan to ease power sector debt  Pakistan to sign term sheets for $4.5 bln loanRepayment over 5-7 years at floating rateLoan to eliminate energy sector debt, a key IMF ref","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nL3N3PQ0V7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4504","BK4516","BK4550","IE0002270589.USD","LU1868836914.USD","LU2471134879.HKD","BK4552","LU1868837136.USD","LU2237443895.HKD","LU1868836591.USD","BK4127","BK4588","IE00BFXG1179.USD","LU2237443622.USD","LU2471134523.USD","LU1868837300.USD","LU2237438978.USD","LU2237443465.HKD","IE00B19Z3581.USD","LU2237443549.SGD","BK4585","LU0096364046.USD","LU2237443978.SGD","IE00B19Z3B42.SGD","LU2750360997.AUD","IE0034235188.USD","LU0106831901.USD","LU0061475181.USD","IE0004091025.USD","LU2750360641.GBP","LU2237443382.USD","LU2471134796.USD","LU2471134952.CNY","IE0004086264.USD","LU1791807156.HKD","BK4533","IE00BSNM7G36.USD","LU1868836757.USD","LU1668664300.SGD"],"gpt_icon":0},{"id":"2517448228","title":"Vertex Pharmaceuticals' Triple Combination Cystic Fibrosis Therapy Alyftrek Receives Approval in UK","url":"https://stock-news.laohu8.com/highlight/detail?id=2517448228","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517448228?lang=en_us&edition=fundamental","pubTime":"2025-03-07 20:46","pubTimestamp":1741351613,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals' (VRTX) triple combination medicine deutivacaftor, tezacaftor,vanzacaftor was approved by the UK's Medicines and Healthcare products Regulatory Agency for treating cystic fibros","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B894F039.SGD","LU0079474960.USD","BK4585","IE00B4R5TH58.HKD","LU1093756168.USD","IE00B19Z9Z06.USD","BK4533","IE0002141913.USD","IE00BZ9MQY76.HKD","BK4567","IE00BJJMRZ35.SGD","LU1093756325.SGD","BK4532","LU2324357040.USD","LU2417539215.USD","LU0058720904.USD","IE00B19Z9P08.USD","LU2236285917.USD","LU2462157665.USD","LU2456880835.USD","LU2362540622.SGD","LU0234570918.USD","LU0256863811.USD","IE0009355771.USD","VERX","LU0109394709.USD","IE00BFTCPJ56.SGD","VRTX","LU2362541273.HKD","LU2362541513.USD","IE00BJT1NW94.SGD","IE0002270589.USD","LU0061475181.USD","LU0889565916.HKD","LU0320765992.SGD","LU1035775433.USD","IE00B19Z3B42.SGD","LU0417517546.SGD","BK4139","LU1069344957.HKD","LU0823416689.USD","IE00B2B36J28.USD","LU1585245621.USD","BK4588","LU1430594728.SGD","LU2237438978.USD","LU0289739699.SGD","IE00B19Z3581.USD"],"gpt_icon":0},{"id":"2517482699","title":"Goldman Sachs Remains a Buy on Venture Global, Inc. Class A (VG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517482699","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517482699?lang=en_us&edition=fundamental","pubTime":"2025-03-07 20:38","pubTimestamp":1741351101,"startTime":"0","endTime":"0","summary":"Goldman Sachs analyst John Mackay maintained a Buy rating on Venture Global, Inc. Class A (VG – Research Report) today and set a price target of $2...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/goldman-sachs-remains-a-buy-on-venture-global-inc-class-a-vg?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/goldman-sachs-remains-a-buy-on-venture-global-inc-class-a-vg?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1791807156.HKD","BK4550","BK4585","LU2471134796.USD","IE00BFXG1179.USD","IE00B19Z3581.USD","LU1668664300.SGD","LU2750360997.AUD","BK4533","LU1868836914.USD","LU2471134523.USD","BK4127","LU1868837136.USD","LU2237443382.USD","IE0034235188.USD","VG","LU2237443465.HKD","LU2237443622.USD","BK4504","LU0061475181.USD","BK4516","LU1868836757.USD","BK4588","IE00BSNM7G36.USD","LU2237443978.SGD","LU2237443549.SGD","LU0096364046.USD","LU2471134952.CNY","LU0106831901.USD","BK4213","IE0002270589.USD","LU1868836591.USD","BK4552","IE0004091025.USD","LU2237443895.HKD","LU2237438978.USD","LU1868837300.USD","IE00B19Z3B42.SGD","IE0004086264.USD","LU2471134879.HKD","BK4023","LU2750360641.GBP"],"gpt_icon":0},{"id":"2517482661","title":"Broadcom (AVGO): New Buy Recommendation for This Technology Giant","url":"https://stock-news.laohu8.com/highlight/detail?id=2517482661","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517482661?lang=en_us&edition=fundamental","pubTime":"2025-03-07 20:37","pubTimestamp":1741351040,"startTime":"0","endTime":"0","summary":"Truist Financial analyst William Stein maintained a Buy rating on Broadcom (AVGO – Research Report) today and set a price target of $267.00. Stein ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/broadcom-avgo-new-buy-recommendation-for-this-technology-giant-20?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/broadcom-avgo-new-buy-recommendation-for-this-technology-giant-20?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0942090050.USD","LU0320765646.SGD","IE00BWXC8680.SGD","LU2108987350.USD","LU2430703178.SGD","LU1989764748.USD","LU2237443978.SGD","AVGO","LU0234572021.USD","LU1914381329.SGD","LU2237443549.SGD","IE00BK4W5M84.HKD","LU0345770308.USD","IE00B19Z9Z06.USD","LU2750360641.GBP","LU2750360997.AUD","BK4605","SG9999015978.USD","SG9999004303.SGD","IE00BKVL7J92.USD","LU0965509010.AUD","IE00B5949003.HKD","IE00BMPRXR70.SGD","LU0912757837.SGD","BK4533","LU0553294199.USD","LU1037948897.HKD","LU2211815571.USD","LU0545039389.USD","SG9999015952.SGD","LU2237957902.USD","LU0079474960.USD","LU1670711123.USD","LU1323610961.USD","LU0661504455.SGD","LU0354030511.USD","AVGOP","LU0234570918.USD","LU0345769128.USD","LU2361045086.USD","IE00BGHQF631.EUR","IE00B42XCP33.USD","LU0444973449.USD","LU2347655156.SGD","LU1803068979.SGD","LU1316542783.SGD","LU1244550221.USD","LU1852331112.SGD","BK4512","BK4566"],"gpt_icon":0},{"id":"2517482823","title":"Humana Says CEO James a. Rechtin's 2024 Total Compensation Was $15.6 Mln – SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2517482823","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517482823?lang=en_us&edition=fundamental","pubTime":"2025-03-07 20:35","pubTimestamp":1741350956,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nFWN3PQ0FM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0266013472.USD","LU1093756168.USD","LU0320765489.SGD","SG9999014021.USD","LU0348723411.USD","LU0070302665.USD","HUM","LU0390134368.USD","LU1983260115.SGD","BK4588","LU1093756325.SGD","LU0170899867.USD","LU0238689110.USD","BK4585","SG9999014005.SGD","LU0208291251.USD","LU0211331839.USD","BK4154","SG9999014013.SGD","BK4533","BK4566","LU0256863811.USD","LU0417517546.SGD"],"gpt_icon":0},{"id":"2517482613","title":"Stifel Nicolaus Remains a Buy on Costco (COST)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517482613","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517482613?lang=en_us&edition=fundamental","pubTime":"2025-03-07 20:33","pubTimestamp":1741350791,"startTime":"0","endTime":"0","summary":"In a report released today, Mark Astrachan from Stifel Nicolaus maintained a Buy rating on Costco (COST – Research Report), with a price target of ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-remains-a-buy-on-costco-cost-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-remains-a-buy-on-costco-cost-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4155","LU2360032135.SGD","LU1496350171.SGD","LU0079474960.USD","LU0820561909.HKD","BK4504","IE0008368304.USD","LU1323610961.USD","LU1116320901.HKD","LU1551013425.SGD","LU2125154935.USD","BK4585","BK4533","LU0417517546.SGD","LU2095319765.USD","LU0471298777.SGD","LU0265550359.USD","IE00B5TLWC47.USD","LU1571399168.USD","BK4581","IE00BZ1G4Q59.USD","LU1069344957.HKD","LU0820561818.USD","LU1066053197.SGD","LU2237438978.USD","LU1066051498.USD","IE00BKVL7J92.USD","LU0385154629.USD","COST","BK4588","LU1035775433.USD","LU0256863811.USD","BK4127","LU2210150020.SGD","LU0471298694.HKD","LU0689472784.USD","LU0943347566.SGD","LU1496350502.SGD","LU2125154778.USD","LU1116320737.USD","SF","LU0234572021.USD","LU2210149790.SGD","LU0234570918.USD","BK4596","LU2360106947.USD","LU0265550946.USD","BK4550","LU1551013342.USD"],"gpt_icon":0},{"id":"2517859438","title":"Broadcom's AI Boom Lifts Q1 Results, Stock Jumps Over 11% in Pre-Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2517859438","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517859438?lang=en_us&edition=fundamental","pubTime":"2025-03-07 20:29","pubTimestamp":1741350556,"startTime":"0","endTime":"0","summary":"Broadcom  shares surged in after-hours trading on Thursday and continued gaining in Friday's pre-market session, rising +11.08% to $199.33 as of 06:49 ET, after the company posted better-than-expected first-quarter results and guidance, signaling strong AI-related demand.For the quarter ended February 2, Broadcom reported adjusted earnings of $1.60 per share, beating analysts' estimates of $1.50. Revenue climbed 25% year-over-year to $14.92 billion, surpassing the $14.61 billion consensus. Semiconductor solutions revenue was $8.21 billion, while infrastructure software revenue reached $6.7 billion.CEO Hock Tan credited record revenue and adjusted EBITDA growth to AI semiconductor demand, with Q1 AI revenue soaring 77% year-over-year to $4.1 billion. Infrastructure software revenue also jumped 47% to $6.7 billion.For the second quarter, Broadcom expects revenue of approximately $14.9 billion, ahead of the $14.59 billion estimate, with adjusted EBITDA projected at 66% of total revenue. A","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/broadcoms-ai-boom-lifts-q1-122916072.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2360032135.SGD","LU0889565833.HKD","LU0820561909.HKD","LU2322448957.HKD","IE00B1XK9C88.USD","LU0868494617.USD","LU1917777945.USD","LU1366192091.USD","LU2430703095.HKD","LU0661504455.SGD","LU1814569148.SGD","LU1242518857.USD","LU0861579265.USD","LU1935043023.USD","IE00BKPKM429.USD","LU2361045086.USD","LU1244550577.SGD","SG9999015945.SGD","LU0354030511.USD","LU2430703178.SGD","IE00BVYPNV92.GBP","AVGO","LU0256863902.USD","BK4543","BK4588","LU0466842654.USD","LU2237443549.SGD","AVGOP","LU2237443622.USD","LU1992135472.HKD","LU0198837287.USD","LU1992135399.USD","LU0345769128.USD","LU1037948541.HKD","IE00BZ9MQY76.HKD","LU2505996509.AUD","IE0004445239.USD","LU0719512351.SGD","LU2471134952.CNY","LU2750360641.GBP","LU2750360997.AUD","LU0965509283.SGD","LU1670627923.USD","LU0234570918.USD","LU1989764748.USD","BK4554","LU1244550221.USD","LU0056508442.USD","LU1037948897.HKD","BK4533"],"gpt_icon":1},{"id":"2517471484","title":"Goldman Traders Say Stock Rally Hinges on Knife-Edge Jobs Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2517471484","media":"Bloomberg","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517471484?lang=en_us&edition=fundamental","pubTime":"2025-03-07 20:26","pubTimestamp":1741350413,"startTime":"0","endTime":"0","summary":"Investor sentiment is so poor that even a slightly better-than-expected US jobs report is set to spark a rally in the S&P 500, according to a Goldman Sachs Group Inc. trading desk.","market":"hk","thumbnail":"https://cloudfront-us-east-1.images.arcpublishing.com/bellmediainc/UCGOLVVM5RBEFPAUFYBFAX2WEM.jpg","type":0,"news_type":0,"thumbnails":["https://cloudfront-us-east-1.images.arcpublishing.com/bellmediainc/UCGOLVVM5RBEFPAUFYBFAX2WEM.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bnnbloomberg.ca/business/company-news/2025/03/07/goldman-traders-say-stock-rally-hinges-on-knife-edge-jobs-data/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"bnn_bloomberg_highlight","symbols":["LU2471134523.USD","LU2237443465.HKD","SSO","IE00B19Z3B42.SGD","BK4534","IE00BSNM7G36.USD","IE0002270589.USD","OEF","SDS","LU2750360641.GBP","LU0096364046.USD","LU0106831901.USD","BK4533","IE00BFXG1179.USD","LU2237438978.USD","OEX","BK4550","LU2237443549.SGD","LU1668664300.SGD","IE0004086264.USD","UPRO","LU2471134879.HKD","LU2471134796.USD",".SPX","LU1868837136.USD","IE0004091025.USD","SH","IE00B19Z3581.USD","BK4559","ESmain","LU2237443978.SGD","LU0061475181.USD","IE0034235188.USD","BK4585","LU2237443622.USD","BK4588","IVV","LU1868837300.USD","SPXU","VOO","LU2750360997.AUD","LU1868836914.USD","LU2471134952.CNY","LU1791807156.HKD","LU2237443382.USD","BK4127","LU1868836591.USD","SPY","BK4581","LU2237443895.HKD"],"gpt_icon":0},{"id":"2517849094","title":"Johnson & Johnson Unit's Lazertinib With Amivantamab Approved in UK for Non-Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2517849094","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517849094?lang=en_us&edition=fundamental","pubTime":"2025-03-07 20:25","pubTimestamp":1741350310,"startTime":"0","endTime":"0","summary":"Johnson & Johnson's (JNJ) Janssen-Cilag subsidiary has received marketing authorization in the UK for lazertinib combined with amivantamab to treat adults with a type of non-small cell lung cancer, th","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4504","IE00B2B36J28.USD","LU1280957306.USD","IE00B7SZLL34.SGD","LU1267930813.SGD","LU1674673428.USD","LU1032466523.USD","LU1221951129.SGD","BK4534","IE00BJT1NW94.SGD","LU0122379950.USD","LU1935042991.SGD","LU1196500208.SGD","IE0009355771.USD","BK4588","LU1066051225.USD","LU1894683348.USD","LU1066053197.SGD","LU0320765646.SGD","SG9999002224.SGD","LU1061106388.HKD","LU1261432733.SGD","IE00BVYPNW00.USD","LU2129689605.HKD","LU0098860793.USD","BK4532","BK4007","LU0882574055.USD","LU2602419157.SGD","LU0345769631.USD","LU1585245621.USD","BK4581","BK4559","LU1506573853.SGD","IE00BJJMRZ35.SGD","LU1430594728.SGD","LU1778281490.HKD","LU1032955483.USD","SG9999001440.SGD","JNJ","LU0345770308.USD","IE00BFTCPJ56.SGD","BK4533","LU1244550221.USD","LU2089984988.USD","LU2430703095.HKD","LU2133065610.SGD","LU0640476718.USD","LU0234572021.USD","LU0345770993.USD"],"gpt_icon":0},{"id":"2517636484","title":"Market Chatter: Goldman Sachs Pushes Some Senior Staff to Relocate or Quit","url":"https://stock-news.laohu8.com/highlight/detail?id=2517636484","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517636484?lang=en_us&edition=fundamental","pubTime":"2025-03-07 20:22","pubTimestamp":1741350138,"startTime":"0","endTime":"0","summary":"Goldman Sachs  is requiring some senior employees to transfer to lower-cost cities such as Dallas and Salt Lake City or leave, Bloomberg News reported Friday, citing citing sources familiar with the matter.The move is focused on shifting management roles away from major financial centers, as part of an ongoing effort to reduce expenses by $1.3 billion while strengthening operations in growing regional offices, the news outlet reported.The bank's Dallas office has expanded significantly, becoming one of its largest global locations, while hiring at its New York headquarters has stagnated, according to the report.The restructuring has mainly affected low and mid-level roles, which raises concerns about the need for more senior leadership in these satellite offices, Bloomberg quoted the sources as saying.Goldman Sachs did not immediately respond to MT Newswires' request for comment.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE0034235188.USD","BK4504","IE00BFXG1179.USD","BK4533","IE00B19Z3581.USD","LU2471134952.CNY","LU2237443622.USD","LU0106831901.USD","BK4127","LU2237443549.SGD","LU1868836914.USD","IE00BSNM7G36.USD","LU1868836757.USD","BK4552","IE0002270589.USD","BK4550","IE0004091025.USD","IE00B19Z3B42.SGD","LU2237443465.HKD","BK4585","LU2471134523.USD","LU0096364046.USD","LU2471134879.HKD","LU2750360641.GBP","LU2237443978.SGD","LU1868837300.USD","LU1868836591.USD","LU2237438978.USD","LU2471134796.USD","LU1668664300.SGD","LU2237443895.HKD","IE0004086264.USD","LU1868837136.USD","BK4516","LU0061475181.USD","BK4588","LU2750360997.AUD","GS","LU1791807156.HKD","LU2237443382.USD"],"gpt_icon":0},{"id":"2517845354","title":"Positive Outlook for Jazz Pharmaceuticals: Buy Rating Backed by Strong Growth Prospects and Strategic Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2517845354","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517845354?lang=en_us&edition=fundamental","pubTime":"2025-03-07 20:17","pubTimestamp":1741349872,"startTime":"0","endTime":"0","summary":"Sean Laaman, an analyst from Morgan Stanley, has initiated a new Buy rating on Jazz Pharmaceuticals (JAZZ). Sean Laaman has given his Buy rating du...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/positive-outlook-for-jazz-pharmaceuticals-buy-rating-backed-by-strong-growth-prospects-and-strategic-focus?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/positive-outlook-for-jazz-pharmaceuticals-buy-rating-backed-by-strong-growth-prospects-and-strategic-focus?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0109394709.USD","LU2111349929.HKD","BK4533","LU0158827948.USD","LU2089283258.USD","LU1989772923.USD","IE00BN0W2W23.USD","LU0314104364.USD","LU0320765646.SGD","LU2089284900.SGD","LU0912757837.SGD","LU1363072403.SGD","LU2028103732.USD","BK4585","LU0158827781.USD","LU0106831901.USD","LU1989772840.SGD","IE00BN0W2T93.GBP","BK4127","JAZZ","LU1732800096.USD","LU1668664300.SGD","LU0971096721.USD","LU0823416689.USD","LU1162221912.USD","IE00BN0W2V16.EUR","LU2271345857.HKD","LU0225283273.USD","BK4504","LU0795875086.SGD","IE00BZ1G4Q59.USD","BK4516","LU2023251221.USD","BK4581","BK4534","BK4007","BK4588","LU0320765992.SGD","LU0267386448.USD","LU1720051017.SGD","LU1074936037.SGD","LU1732799900.SGD","LU2133065610.SGD","IE00BKVL7J92.USD","LU2347655156.SGD","LU0795875169.SGD","LU0106261372.USD","LU0889565916.HKD","LU0006306889.USD","BK4532"],"gpt_icon":0}],"pageSize":16,"totalPage":206,"pageCount":16,"totalSize":3293}]}}